MAPPING AND TREATING EARLY CLINICAL STAGES OF MENTAL DISORDERS DURING TRANSITION TO ADULTHOOD

Grant number: 1060996 | Funding period: 2014 - 2018

Completed

Abstract

The research proposed in this Fellowship is aimed at young people with emerging mental ill-health. The specific goals and targets are to formulate novel diagnoses that work; develop novel, personalised and safe psychosocial and biotherapies; and scale up well-evaluated 21st century models of mental health care.

Related publications (16)

Scholarly works icon

Adolescent and Young Adult Male Mental Health: Transforming System Failures Into Proactive Models of Engagement

Simon M Rice, Rosemary Purcell, Patrick D McGorry

2018-03-01

Scholarly works icon

Improving outcomes of first-episode psychosis: an overview

Paolo Fusar-Poli, Patrick D McGorry, John M Kane

2017-10-01

Scholarly works icon

Omega-6 to omega-3 polyunsaturated fatty acid ratio and subsequent mood disorders in young people with at-risk mental states: a 7-year longitudinal study

ME Berger, S Smesny, S-W Kim, CG Davey, S Rice, Z Sarnyai, M Schloegelhofer, MR Schafer, M Berk, PD McGorry, GP Amminger

2017-08-29

Scholarly works icon

Longitudinal determinants of client treatment satisfaction in an intensive first-episode psychosis treatment programme

Lisa N Cruz, Emily Kline, Larry J Seidman, Kyle S Minor, Eric C Meyer, Carina Iati, Suzanna V Zimmet, Michelle Friedman-Yakoobian

2017-08-01

Scholarly works icon

Quetiapine v. lithium in the maintenance phase following a first episode of mania: randomised controlled trial

Michael Berk, Rothanthi Daglas, Orwa Dandash, Murat Yucel, Lisa Henry, Karen Hallam, Craig Macneil, Melissa Hasty, Christos Pantelis, Brendan P Murphy, Linda Kader, Saji Damodaran, Michael TH Wong, Philippe Conus, Aswin Ratheesh, Patrick D McGorry, Sue M Cotton

2017-06-01

Scholarly works icon

Back to the future: Schizophrenia in retrospect and prospect

Patrick D McGorry

2017-05-01

Scholarly works icon

Novel biotherapies are needed in youth mental health

G Paul Amminger, Maximus Berger, Simon M Rice, Christopher G Davey, Miriam R Schafer, Patrick D McCorry

2017-04-01

Scholarly works icon

Erythrocyte glutathione levels as long-term predictor of transition to psychosis

S Lavoie, M Berger, M Schloegelhofer, MR Schaefer, S Rice, S-W Kim, J Hesse, PD McGorry, S Smesny, GP Amminger

2017-03-21

Scholarly works icon

Opening the Black Box of Cognitive-Behavioural Case Management in Clients with Ultra-High Risk for Psychosis

Jessica A Hartmann, Patrick D McGorry, Stefanie J Schmidt, G Paul Amminger, Hok Pan Yuen, Connie Markulev, Gregor E Berger, Eric YH Chen, Lieuwe de Haan, Ian B Hickie, Suzie Lavoie, Meredith J McHugh, Nilufar Mossaheb, Dorien H Nieman, Merete Nordentoft, Anita Riecher-Roessler, Miriam R Schafer, Monika Schloegelhofer, Stefan Smesny, Andrew Thompson

2017-01-01

Scholarly works icon

Differential expression of the inflammation marker IL12p40 in the at-risk mental state for psychosis: a predictor of transition to psychotic disorder?

Melanie Focking, Patrick Dicker, Lorna M Lopez, Mary Cannon, Miriam R Schafer, Patrick D McGorry, Stefan Smesny, David R Cotter, G Paul Amminger

2016-09-20

Scholarly works icon

White matter integrity in individuals at ultra-high risk for psychosis: a systematic review and discussion of the role of polyunsaturated fatty acids

Nandita Vijayakumar, Cali Bartholomeusz, Thomas Whitford, Daniel F Hermens, Barnaby Nelson, Simon Rice, Sarah Whittle, Christos Pantelis, Patrick McGorry, Miriam R Schafer, G Paul Amminger

2016-08-11

Scholarly works icon

Baseline grey matter volume of non-transitioned "ultra high risk" for psychosis individuals with and without attenuated psychotic symptoms at long-term follow-up

Vanessa L Cropley, Ashleigh Lin, Barnaby Nelson, Renate LEP Reniers, Alison R Yung, Cali F Bartholomeusz, Paul Klauser, Dennis Velakoulis, Patrick McGorry, Stephen J Wood, Christos Pantelis

2016-06-01

Scholarly works icon

Beyond Clinical Remission in First Episode Psychosis: Thoughts on Antipsychotic Maintenance vs. Guided Discontinuation in the Functional Recovery Era

M Alvarez-Jimenez, B O'Donoghue, A Thompson, JF Gleeson, S Bendall, C Gonzalez-Blanch, E Killackey, L Wunderink, PD McGorry

2016-05-01

Scholarly works icon

Longer-term outcome in the prevention of psychotic disorders by the Vienna omega-3 study

G Paul Amminger, Miriam R Schaefer, Monika Schloegelhofer, Claudia M Klier, Patrick D McGorry

2015-08-01

Scholarly works icon

The relationship between stress, HPA axis functioning and brain structure in first episode psychosis over the first 12 weeks of treatment

Renate LEP Reniers, Belinda Garner, Christina Phassouliotis, Lisa J Phillips, Connie Markulev, Christos Pantelis, Sarah Bendall, Patrick D McGorry, Stephen J Wood

2015-02-28

Scholarly works icon

Predictors of treatment response in young people at ultra-high risk for psychosis who received long-chain omega-3 fatty acids

GP Amminger, A Mechelli, S Rice, S-W Kim, CM Klier, RK McNamara, M Berk, PD McGorry, MR Schaefer

2015-01-13